1. Home
  2. NA vs JSPR Comparison

NA vs JSPR Comparison

Compare NA & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nano Labs Ltd

NA

Nano Labs Ltd

HOLD

Current Price

$0.81

Market Cap

30.1M

Sector

Technology

ML Signal

HOLD

Logo Jasper Therapeutics Inc.

JSPR

Jasper Therapeutics Inc.

N/A

Current Price

$10.00

Market Cap

26.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NA
JSPR
Founded
2019
2018
Country
China
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
30.1M
26.3M
IPO Year
2021
2019

Fundamental Metrics

Financial Performance
Metric
NA
JSPR
Price
$0.81
$10.00
Analyst Decision
Buy
Analyst Count
0
8
Target Price
N/A
★ $249.83
AVG Volume (30 Days)
21.2K
★ 257.9K
Earning Date
08-28-2026
11-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 19.22
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.85
$0.32
52 Week High
$4.49
$17.03

Technical Indicators

Market Signals
Indicator
NA
JSPR
Relative Strength Index (RSI) 20.41 58.04
Support Level N/A $0.64
Resistance Level $2.06 $17.03
Average True Range (ATR) 0.20 1.67
MACD -0.04 -0.06
Stochastic Oscillator 7.53 54.49

Price Performance

Historical Comparison
NA
JSPR

About NA Nano Labs Ltd

Nano Labs Ltd is a Web 3.0 infrastructure and product solution provider, as well as a crypto treasury company. It is focused on the development of HTC chips and HPC chips. In addition, the company has established BNB value investment and adopted BNB (a crypto token) as the primary reserve asset. Furthermore, it has launched the iPollo Claw, a dedicated hardware solution for the OpenClaw AI Agent Ecosystem. Nano Labs derives revenue mainly from its HTC and HPC offerings, which comprise Darkbird series HPC chips that feature high performance and high energy consumption efficiency, and Cuckoo series chips, used in GPUs. Geographically, the company generates maximum revenue from the People's Republic of China (PRC), and the rest from Singapore, Hong Kong, the United States, and other markets.

About JSPR Jasper Therapeutics Inc.

Jasper Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics targeting mast cell driven diseases such as Chronic Spontaneous Urticaria (CSU), Chronic Inducible Urticaria (CIndU) and asthma. The company's lead product candidate, briquilimab, is a monoclonal antibody designed to block stem cell factor (SCF) from binding to and signaling through the CD117 (KIT) receptor on mast and stem cells. The company has a single operating and reportable segment, which is the research and development of therapeutic products in the fields of chronic urticaria and asthma.

Share on Social Networks: